本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

16.07
+0.01000.06%
盘后16.01-0.0600-0.37%19:35 EDT
成交量:130.20万
成交额:2,119.72万
市值:21.37亿
市盈率:7.76
高:16.54
开:16.17
低:16.06
收:16.06
52周最高:16.54
52周最低:7.29
股本:1.33亿
流通股本:1.28亿
量比:1.38
换手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):2.07
每股收益(LYR):2.07
净资产收益率:59.91%
总资产收益率:11.16%
市净率:3.68
市盈率(LYR):7.76

数据加载中...

2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]